FDA Inspection 1266407 — Department Of Defense - Army
The FDA completed an inspection of Department Of Defense - Army on Mar 21, 2025 in Tripler Army Medical Center, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 21, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tripler Army Medical Center, HI (United States)